Likewise, in 1998, Mansi et al [671], evaluated both 125I-labeled monoclonal antibody B72.3 and 99mTc-labeled fragments of the murine anti-CEA monoclonal antibody F023C5 in lung cancer patients. Here, CEACAM5 is linked to lung carcinoma.